Mark Kirschbaum

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Kirschbaum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Kirschbaum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Chief Medical Officer Stock Option (right to buy) 70.2K 30 Jun 2023 Direct

Insider Reports Filed by Mark Kirschbaum

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 1 $0 4 Chief Medical Officer 03 Jul 2023, 16:56
CYCC Cyclacel Pharmaceuticals, Inc. 31 Jan 2023 1 $0 4 Chief Medical Officer 02 Feb 2023, 15:17
CYCC Cyclacel Pharmaceuticals, Inc. 13 Dec 2021 1 $0 4 Chief Medical Officer 15 Dec 2021, 15:18